Article
Macrophages, Inflammation, and Lung Cancer.
American journal of respiratory and critical care medicine - 15 Jan 2016
Conway Emma M, Pikor Larissa A, Kung Sonia H Y, Hamilton Melisa J, Lam Stephen, Lam Wan L, Bennewith Kevin L
Abstract excerpt
Lung cancer is the leading cause of cancer mortality worldwide, and at only 18%, it has one of the lowest 5-year survival rates of all malignancies. With its highly complex mutational landscape, treatment strategies against lung cancer have proved largely ineffective. However with the recent success of immunotherapy trials in lung cancer, there is renewed enthusiasm in targeting the immune component of tumors....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.